Tricaprin
Skeletal formula of decanoic acid
Names
Preferred IUPAC name
2,3-di(decanoyloxy)propyl decanoate
Other names
Tridecanoin; Glyceryl tricaprate
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
EC Number
  • 210-702-0
UNII
  • InChI=1S/C33H62O6/c1-4-7-10-13-16-19-22-25-31(34)37-28-30(39-33(36)27-24-21-18-15-12-9-6-3)29-38-32(35)26-23-20-17-14-11-8-5-2/h30H,4-29H2,1-3H3
    Key: LADGBHLMCUINGV-UHFFFAOYSA-N
  • CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC
Properties
C33H62O6
Molar mass 554.853 g·mol−1
Appearance White (light yellow?) crystals[1]
Melting point 31 °C (88 °F; 304 K)[1]
Thermochemistry
1109 J/mol·K[2]
-1985.1 kJ/mol[2]
19861.4 ± 1.8 kJ/mol[2]
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
Not classified as a hazardous substance
Lethal dose or concentration (LD, LC):
>10 g/kg (mouse, intravenous)[3]
Safety data sheet (SDS) External MSDS
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Tracking categories (test):

Tricaprin or tridecanoin is a triglyceride of capric acid.[4] Its formula is C33H62O6.

Occurrence edit

Tricaprin occurs naturally in the seeds of Umbellularia californica, a hardwood tree native to North America.[5]

Production edit

Uses edit

Tricaprin is used as an additive to diesel fuel[6] and as part of current and speculative biodiesels.[7][8]

Pharmacological edit

Tricaprin has been indicated as a possible drug to increase the production of insulin and decrease the production of androgen in the body when taken orally.[9] It, along with other medium-chain triglycerides, has been studied as a treatment option to prevent ruptures of abdominal aortic aneurysm,[10] and has been specifically studied as a regulator of membrane functions[11] and in the heart to facilitate lipolysis.[12]

See also edit

References edit

  1. ^ a b "Tricaprin". Sigma-Aldrich. June 18, 2023.
  2. ^ a b c Decanoic acid, 1,2,3-propanetriyl ester in Linstrom, Peter J.; Mallard, William G. (eds.); NIST Chemistry WebBook, NIST Standard Reference Database Number 69, National Institute of Standards and Technology, Gaithersburg (MD)
  3. ^ Wretlind A (October 1957). "The toxicity of low-molecular triglycerides". Acta Physiologica Scandinavica. 40 (4): 338–343. doi:10.1111/j.1748-1716.1957.tb01502.x. PMID 13478501.
  4. ^ Aimo L. "tricaprin (CHEBI:77388)". ChEBI. Retrieved April 12, 2024.
  5. ^ Reynolds T, Dring JV, Hughes C (December 1991). "Lauric acid-containing triglycerides in seeds of umbellularia californica nutt. (Lauraceae)". Journal of the American Oil Chemists' Society. 68 (12): 976–977. doi:10.1007/BF02657546. ISSN 0003-021X.
  6. ^ Eiteman MA, Goodrum JW (1993). "Rheology of the Triglycerides Tricaproin, Tricaprylin, and Tricaprin and of Diesel Fuel". Transactions of the ASAE. 36 (2): 503–507. doi:10.13031/2013.28366. ISSN 2151-0059.
  7. ^ Goodrum JW, Eiteman MA (April 1996). "Physical properties of low molecular weight triglycerides for the development of bio-diesel fuel models". Bioresource Technology. 56 (1): 55–60. doi:10.1016/0960-8524(95)00167-0.
  8. ^ Ferreira IM, de Ganzeli L, Rosset IG, Yoshioka SA, Porto AL (January 2017). "Ethylic Biodiesel Production Using Lipase Immobilized in Silk Fibroin-Alginate Spheres by Encapsulation". Catalysis Letters. 147 (1): 269–280. doi:10.1007/s10562-016-1917-0. ISSN 1011-372X.
  9. ^ "Tricaprin (Code C153424)". NCI Thesaurus. Retrieved April 12, 2024.
  10. ^ Kugo H, Sugiura Y, Fujishima R, Jo S, Mishima H, Sugamoto E, et al. (April 2023). "Tricaprin can prevent the development of AAA by attenuating aortic degeneration". Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 160: 114299. doi:10.1016/j.biopha.2023.114299. PMID 36724640.
  11. ^ Ro SY, Choi HM, Choi SH, Lee SW, Lim SJ (July 2023). "Tricaprin as a membrane permeability regulator: sustained small hydrophilic substance release from liposomes". Journal of Pharmaceutical Investigation. 53 (4): 539–548. doi:10.1007/s40005-023-00621-2. ISSN 2093-5552.
  12. ^ Miyauchi H, Hirano KI, Nakano Y, Shimada K, Nishikawa M, Yamamoto H, et al. (2022). "123I-BMIPP Scintigraphy Shows That CNT-01 (Tricaprin) Improves Myocardial Lipolysis in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy: First Randomized Controlled, Exploratory Trial for TGCV". Annals of Nuclear Cardiology. 8 (1): 67–75. doi:10.17996/anc.22-00167. PMC 9749752. PMID 36540180.